Three-Dimensional Systolic Dyssynchrony Index in Real-Time as a Predictor of Pacing-Related Left Ventricular Dysfunction and Cardiomyopathy - Top-Institutions - MDSpire

Three-Dimensional Systolic Dyssynchrony Index in Real-Time as a Predictor of Pacing-Related Left Ventricular Dysfunction and Cardiomyopathy

  • By

  • Moustafa Dawood

  • Hoda Abdelgawad

  • Aly Aboelhoda

  • Moataz Zaki

  • April 27, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Cardiac Electrophysiology
    • Advanced Cardiac Imaging

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiac Electrophysiology
    • Heart Failure

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Cardiac Electrophysiology
    • Echocardiography

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Cardiac Imaging

  • #5

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Cardiology
    • Cardiac Electrophysiology
    • Biomedical Imaging

Original Source(s)

Three-Dimensional Systolic Dyssynchrony Index in Real-Time as a Predictor of Pacing-Related Left Ventricular Dysfunction and Cardiomyopathy

  • by Moustafa Dawood, Hoda Abdelgawad, Aly Aboelhoda, Moataz Zaki

  • April 27, 2026

Related Content

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

Real-world cohort data show lower epilepsy risk vs DPP-4 inhibitors in older patients with type 2 diabetes

Medical Oddities: Essential Oil, Deadly Consequences

A cabinet mix-up, a chatty heart, a violet catheter bag, stressed kids, and tea that won’t save the brain—just another week.

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation